AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Pharvaris N.V. Ordinary Shares
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00YYCW2H3
31.41▲ 0.73 (2.38%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
30.68
Day's Range
30.25 – 32.12
52-Week Range
21.02 – 43.25
Volume
621.2K
Avg Volume
739.2K
Share Statistics
Shares Outstanding
Employees
129
Exchange
XNAS
Listed
2021-02-05
Share count as of December 31, 2025

Pharvaris N.V. Ordinary Shares (PHVS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Pharvaris N.V. Ordinary Shares (PHVS)
What is Pharvaris N.V. Ordinary Shares's Market Cap?
Pharvaris N.V. Ordinary Shares's Market Cap is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Enterprise Value?
Pharvaris N.V. Ordinary Shares's Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's EV / EBITDA?
Pharvaris N.V. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Net Income (TTM)?
Pharvaris N.V. Ordinary Shares's Net Income (TTM) is -$206.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's EBITDA?
Pharvaris N.V. Ordinary Shares's EBITDA is -$203.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Diluted EPS (TTM)?
Pharvaris N.V. Ordinary Shares's Diluted EPS (TTM) is -3.16, based on as-reported figures from SEC (XBRL) filings.
What is Pharvaris N.V. Ordinary Shares's Net Debt?
Pharvaris N.V. Ordinary Shares's Net Debt is -$342.3M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PHVSAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of EUR, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Profit or loss [abstract]
Research and development expenses
General and administrative expenses
Total operating expenses
Finance (expenses) income
Loss before income tax
Income tax expense
Net Loss